NEW CASTLE, Del., Oct. 11, 2012 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has become an approved vendor of a major top 5 generic pharmaceutical manufacturer.
Being an approved vendor enables ScripsAmerica to distribute products from the major generic pharmaceutical manufacturer to its current and future customers. The approval follows ScripsAmerica's successful completion of a screening process that requires multiple business references and the ability to provide high quality of pharmaceutical distribution services. The Company anticipates that this development will have a positive impact on its ability to acquire new distribution contracts, and better serve its current hospital, nursing home and government facility customers.
"We are very excited to become an approved vendor of this major manufacturer. We believe this will enable ScripsAmerica to expand its customer base by not only increasing the number of pharmaceutical products that we offer on the whole, but also offering the top quality products from the world's largest manufacturer of generic drugs that are in high demand," stated CEO of ScripsAmerica, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies through the largest pharmaceutical distributor in North America, McKesson Corporation. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, Curtis Pharmaceuticals, MedVet and the United States Veterans Administration.
For more information please visit: www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: 888-959-7095Source:ScripsAmerica, Inc.